Health Condition 1: M628- Other specified disorders of muscle
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Sponsors
GSVM Medical College Kanpur
Eligibility
Inclusion criteria
Inclusion criteria: Subjects with diagnosis of COPD based on GOLD Guidelines 2025 and having severity of obstruction as GOLD 1-3 and belonging to GOLD Class A & B. Haemoglobin level equal to or more than 8 g per dl Stable subjects with co-morbidities like diabetes (with HbA1c less than 10 percent hypertension with systolic BP less than140 and DBP less than 90 mm Hg hypothyroidism or hyperthyroidism with normal thyroid function on appropriate therapy CKD stage 1 and 2 Heart Failure NYHA class I and II will be eligible for participation. They should be on stable dose for last at least three months.
Exclusion criteria
Exclusion criteria: Acute on chronic exacerbation of COPD Presence of Cor Pulmonale History of hospitalization in last three months Malignancy CKD (stage greater than or equal to 3) Heart Failure (NYHA III or IV) COPD with severity of obstruction GOLD 4 and GOLD Stage E Neuromuscular disease (such as myasthenia gravis, MND) Stroke or other neurologic disorder with residual deficit Infections like HIV, active pulmonary or extrapulmonary TB Critical illness Organ transplant or immunosuppression Pregnancy or lactation Long term steroid use (except inhaled or topical) Bedridden subjects due to their inability in performing the required tests Subjects having locomotor abnormalities
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of Sarcopenia among subjects with COPDTimepoint: Baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life using SARQOLTimepoint: Single | — |
Countries
India
Contacts
Public ContactDr Himanshu Maurya
KPS Post Graduate Institute of Medicine , GSVM Medical college kanpur
Outcome results
None listed